TScan Therapeutics, Inc. - TCRX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Chief Financial Officer | A | A | 350,000.0 | 0.0 | 0.0 | 350,000.0 | View | |
| Jan 22, 2026 | Chief Executive Officer | A | A | 1,165,000.0 | 0.0 | 0.0 | 1,165,000.0 | View | |
| Jan 22, 2026 | See Remarks | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jan 22, 2026 | Chief Medical Officer | A | A | 420,000.0 | 0.0 | 0.0 | 420,000.0 | View | |
| Jan 22, 2026 | See Remarks | A | A | 350,000.0 | 0.0 | 0.0 | 350,000.0 | View | |
| Dec 23, 2025 | — | P | A | 6,232.0 | 0.8989 | 5,601.94 | 8,019,148.0 | View | |
| Dec 23, 2025 | — | P | A | 75,500.0 | 0.9 | 67,950.0 | 8,012,916.0 | View | |
| Dec 23, 2025 | — | P | A | 80,069.0 | 0.8989 | 71,974.02 | 7,937,416.0 | View |